| Issuer | % of Class | Filed |
|---|---|---|
|
Tevogen Inc.
13D/A
Amendment 5
TVGN · 88165K200
|
91.1% |
11/4/2026
Event 11/2/2026
|
|
Tevogen Inc.
13D/A
Amendment 4
TVGN · 88165K200
|
74.4% |
9/16/2026
Event 9/14/2026
|
|
Tevogen Bio Holdings Inc.
13D/A
Amendment 3
TVGN · 88165K101
|
59.7% |
7/14/2026
Event 7/10/2026
|
|
Tevogen Bio Holdings Inc.
13D/A
Amendment 2
TVGN · 88165K101
|
62.0% |
12/16/2025
Event 12/11/2025
|
|
Tevogen Bio Holdings Inc.
13D/A
Amendment 1
TVGN · 88165K101
|
64.5% |
7/25/2025
Event 6/27/2025
|
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.